Jasper Therapeutics (JSPR) Free Cash Flow (2020 - 2026)
Jasper Therapeutics (JSPR) free cash flow from Mar 31, 2020 to Mar 31, 2026. The TTM Jasper Therapeutics (JSPR) free cash flow is -$69M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Jasper Therapeutics (JSPR) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.19% |
| 3 Years TTM | +17.94% |
| 5 Years TTM | +148.28% |
| All Time TTM | +148.31% |
Annual Free Cash Flow change of Jasper Therapeutics (JSPR)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$15M | -81.14% |
| 2025 | -$77M | +23.26% |
| 2024 | -$63M | +20.22% |
| 2023 | -$52M | +13.54% |
| 2022 | -$46M | +36.16% |
| 2021 | -$34M | +5162.50% |
| 2020 | -$640K | +72.97% |
| 2019 | -$370K | N/A |
Comparison Jasper Therapeutics (JSPR) five years free cash flow CAGR with competitors
Jasper Therapeutics (JSPR) five years free cash flow CAGR is 148.56%.